2015•Journal watchRequires access

Intraperitoneal Chemotherapy for Advanced Ovarian Cancer

Virginia Kaklamani

Abstract

A 2006 study showed that adding intraperitoneal (IP) chemotherapy to intravenous (IV) chemotherapy following surgery significantly improves survival in women with stage III ovarian cancer (N Engl J Med 2006; 354:34), prompting the National Cancer Institute to urge the adoption of this approach. However, given barriers to the acceptance of combination IP/ IV chemotherapy — such as perceived toxicities, the potential …

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Ovarian cancer, Intraperitoneal chemotherapy, Chemotherapy, Oncology, Internal medicine, Stage (stratigraphy), Cancer